YieldMax MRNA Option Income Strategy ETF (MRNY) Short Interest Ratio & Short Volume

Short interest is the volume of YieldMax MRNA Option Income Strategy ETF shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 425,600 shares of MRNY short. 0.81% of YieldMax MRNA Option Income Strategy ETF's shares are currently sold short. Learn More on YieldMax MRNA Option Income Strategy ETF's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of YieldMax MRNA Option Income Strategy ETF: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of YieldMax MRNA Option Income Strategy ETF's floating shares are currently sold short.

YieldMax MRNA Option Income Strategy ETF saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 425,600 shares, a decrease of 69.2% from the previous total of 1,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.81% of YieldMax MRNA Option Income Strategy ETF's shares are currently sold short. Here is how the short interest of companies compare to YieldMax MRNA Option Income Strategy ETF: Defiance Daily Target 2X Long IONQ ETF (5.09%), GraniteShares YieldBOOST NVDA ETF (3.38%), Defiance Daily Target 2X Long AVGO ETF (17.27%), Tradr 2X Long APP Daily ETF (1.32%), YieldMax Innovation Option Income Strategy ETF (4.76%), Direxion Daily TSM Bull 2X Shares (0.17%), YieldMax SNOW Option Income Strategy ETF (0.75%), Defiance Daily Target 2X Long LLY ETF (8.67%), Defiance Leveraged Long + Income MSTR ETF (16.75%), Defiance Daily Target 2X Long RKLB ETF (13.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling MRNY is an investing strategy that aims to generate trading profit from YieldMax MRNA Option Income Strategy ETF as its price is falling. MRNY shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for YieldMax MRNA Option Income Strategy ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNY, twice per month. The most recent reporting period available is August, 31 2025.